These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Influence of time (4 years) on the results of programmed ventricular stimulation]. Brembilla-Perrot B, Jacquemin L, Houriez P, Houplon P, Claudon O, Beurrier D, Terrier de la Chaise A, Louis P. Arch Mal Coeur Vaiss; 1998 Mar; 91(3):301-7. PubMed ID: 9749234 [Abstract] [Full Text] [Related]
48. Clinical investigation: Utility of left ventricular end diastolic diameter in the prediction of susceptibility to ventricular tachyarrhythmias. Makaryus AN, Catanzaro JN, Hametz CD, Jadonath RL. Int J Cardiol; 2007 Sep 03; 120(3):399-403. PubMed ID: 17188377 [Abstract] [Full Text] [Related]
49. QT and JT dispersion in patients with monomorphic or polymorphic ventricular tachycardia/ventricular fibrillation. Shimizu H, Ohnishi Y, Inoue T, Yokoyama M. J Electrocardiol; 2001 Apr 03; 34(2):119-25. PubMed ID: 11320459 [Abstract] [Full Text] [Related]
51. Nifekalant hydrochloride terminating sustained ventricular tachycardia accompanied with QT dispersion prolongation. Wang J, Hua W, Zhu J, Yang YM, Wang FZ, Pu JL, Chen KP, Zhang S. Chin Med J (Engl); 2010 Aug 05; 123(15):2028-33. PubMed ID: 20819537 [Abstract] [Full Text] [Related]
52. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Pye M, Quinn AC, Cobbe SM. Br Heart J; 1994 Jun 05; 71(6):511-4. PubMed ID: 8043329 [Abstract] [Full Text] [Related]
55. [QT dispersion in surface ECG and QT dynamics in long-term ECG in patients with coronary heart disease in the chronic post-infarct stage with and without ventricular tachyarrhythmias--correlation with other risk parameters]. Walter T, Griessl G, Kluge P, Neugebauer A. Z Kardiol; 1997 Mar 05; 86(3):204-10. PubMed ID: 9173711 [Abstract] [Full Text] [Related]
57. Comparative usefulness of beat-to-beat QT dispersion and QT interval fluctuations for identifying patients with organic heart disease at risk for ventricular arrhythmias. Galeano EJ, Yoshida A, Ohnishi Y, Okajima K, Ishida A, Kitamura H, Kubo S, Yokoyama M. Circ J; 2003 Feb 05; 67(2):125-8. PubMed ID: 12547993 [Abstract] [Full Text] [Related]
58. Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Chauhan VS, Downar E, Nanthakumar K, Parker JD, Ross HJ, Chan W, Picton P. Am J Physiol Heart Circ Physiol; 2006 Jan 05; 290(1):H79-86. PubMed ID: 16113076 [Abstract] [Full Text] [Related]
59. Relationship between QT interval duration and electrical induction of ventricular tachycardia. Dabrowski A, Kolodziej P, Krupienicz A. Pacing Clin Electrophysiol; 1991 Feb 05; 14(2 Pt 2):366-9. PubMed ID: 1706854 [Abstract] [Full Text] [Related]
60. Ventricular arrhythmias in patients with COPD are associated with QT dispersion. Yildiz P, Tükek T, Akkaya V, Sözen AB, Yildiz A, Korkut F, Yilmaz V. Chest; 2002 Dec 05; 122(6):2055-61. PubMed ID: 12475847 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]